Thymine base editor of organelle genome, expression vector and application

By using transport peptides, TALE arrays and DNA nickases and glycosylases in the organelle genome, efficient T-to-S base editing is achieved without deaminase-dependent, solving the accuracy and targeting of organelle genome editing. The problem fills the gap in the existing technology.

CN118995666APending Publication Date: 2024-11-22EIGHTH AFFILIATED HOSPITAL SUN YAT SEN UNIV (SHENZHEN FUTIAN)
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202410959918.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-16
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

In the prior art, T-base editing of organelle genomes is difficult to achieve efficient and accurate, and deaminase-dependent deaminase will lead to off-target effects, and there is a lack of selective and efficient editing technology for target DNA strands that do not rely on deaminase.

Method used

The organelles genome thymine base editor consisting of transport peptides, TALE arrays, DNA nickases and engineered thymine DNA glycosylase are used to accurately localize the organelles genome through the TALE array, and use DNA nickases and glycosylase. Implement T to S base editing to avoid the use of deaminase.

Benefits of technology

It realizes T-S base editing with low off-target effects on the organelle genome, improves editing accuracy, is suitable for the chloroplast and mitochondrial genome of eukaryotes, and expands the application scope of base editors.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995666A_ABST
    Figure CN118995666A_ABST
Patent Text Reader

Abstract

The invention discloses an organelle genome thymine base editor, an expression vector and application. The base editor comprises a left fusion protein and a right fusion protein, the left fusion protein sequentially comprises a transport peptide, TALE-L, DNA nickase and DNA excision enzyme, and the right fusion protein sequentially comprises a transport peptide, TALE-R and thymine DNA glycosylase. According to the base editor disclosed by the invention, firstly, the base editor is guided to enter an organelle genome target site by utilizing a transport peptide and a TALE array, so that the limitation that the current gTBE can only target a nuclear genome and cannot target the organelle genome is overcome; secondly, the T-to-S base editing of organelle genomes is realized by utilizing DNA nicking enzyme and engineered thymine DNA glycosylase, so that the use of deaminase is avoided, and non-target base editing caused by the deaminase is reduced; and thirdly, T base editing has DNA chain selectivity, so that the accuracy of base editing is enhanced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of base editors, and in particular to an organelle genome thymine base editor, an expression vector and applications. Background Art

[0002] Chloroplasts and mitochondria in higher organisms are semi-autonomous organelles that contain their own genomic DNA (ptDNA and mtDNA). The chloroplast (plastid) genome (plastome, ptDNA), usually 110 to 200 Kb, encodes about 130 proteins and RNA molecules that are essential for plant photosynthesis. During leaf development, the number of chloroplasts per plant cell and the number of genome copies per chloroplast vary greatly. At the same time, the plastome is an allopolyploid genome.

[0003] The size of the mitochondrial genome (mtDNA) varies greatly among species. Human mtDNA is about 16.5Kb in size and contains 37 genes, encoding tRNA (22 types), 12S rRNA, 16S rRNA, and 13 proteins. Each human cell generally contains 2 to 10 mtDNA molecules. In comparison, plant mtDNA is much larger than that of other eukaryotic organisms, with a size generally ranging from 66Kb to 11Mb, containing 50 to 60 genes, and is inherited from a single parent. Editing and modifying ptDNA and mtDNA sequences has important application value and practical significance. Application scenarios include repairing human mtDNA mutations, achieving treatment of diseases caused by mitochondrial mutations, modifying plant ptDNA and mtDNA genes for photosynthesis, utilizing hybrid vigor, and other related important agronomic traits. In short, ptDNA and mtDNA base editing has great application prospects in a wide range of fields such as life sciences, medicine, and agriculture.

[0004] In recent years, genome editing technology has developed rapidly. Widely used genome editing tools include engineered zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas, CRISPR / Cas). These editing tools can introduce double-stranded DNA breaks (DSBs) or chemical changes in DNA bases, such as deamination of cytosine, at selected genomic sites. DNA repair of DSBs and chemical changes during the repair process can lead to the expected DNA sequence variation of the user. Because DSBs may induce genomic instability, genome editing technologies that do not rely on DSBs have been developed and applied. Currently, genome editing technologies that do not rely on DSBs, such as base editing and prime editing, have been developed.

[0005] Genomic base editors can achieve single nucleotide editing, with the advantages of high precision and high efficiency, and are powerful scientific research tools in the fields of life sciences and medicine. Base editors are usually based on the CRISPR / Cas system, consisting of a Cas nickase (e.g., Cas9D10A nickase) fused with a DNA modification enzyme. The Cas nickase and guide RNA (gRNA) complex guides the base editor to target the DNA target site, and then the DNA modification enzyme modifies the target site to obtain the desired genetic variation. Using single-stranded or double-stranded DNA deaminases, such as tRNA adenosine deaminase TadA, AID / APOBEC-like cytidine deaminase, DddA variants, and more Sdd deaminases, a variety of DNA base editors have been developed, including adenine base editors (ABE), cytosine base editors (CBE), and double-stranded DNA deaminase toxin A (DddA) derived cytosine base editors (DdCBE), and their derivatives, such as A&C-BEmax, AYBE, AXBE, and CGBE. The above can be classified as deaminase-based base editors (dBE). Since deaminases can cause a large number of off-target mutations in cellular DNA and RNA, a class of deaminase-independent base editors (gBE) has recently been developed using glycosylases. Reported gBEs include glycosylase-based deaminase-free guanine base editors (gGBE) and cytosine base editors (gCBE).

[0006] The above base editors are mainly used for DNA editing of nuclear genomes. In comparison, base editing technology for organelle genomes, including mitochondria and chloroplasts, lags behind that of nuclear genomes. One of the important reasons is that the gRNA component of CRISPR is difficult to deliver to the organelles of eukaryotic organisms, which hinders the application of CRISPR / Cas-based base editors in organelle genomes. At present, organelle genome base editors are composed of transcription activator-like effector (TALE) arrays fused with DNA modification enzymes, including DdCBE cytosine base editors, TALED adenine base editors, CyDENT cytosine base editors, and mitoBEs mitochondrial DNA base editors. These are all organelle genome editors that rely on deaminases. It has been reported that deaminases can cause a large number of off-target mutations in cellular RNA and DNA that are independent of Cas9 or TALE arrays, and fusion deaminases are the main cause of the off-target effects of these base editors. Therefore, the development of organelle base editing technology that does not rely on deaminases is of great practical significance.

[0007] A study reported a deaminase-independent thymine base editor (gTBE) developed using engineered human uracil DNA glycosylase (UNG), which can achieve genomic DNA T to S base editing. gTBE was developed by fusing Cas9 nickase (nCas9) with an engineered UNG variant and has the ability to directly edit T bases. In cultured human cells, gTBE exhibited a high T-to-S (i.e., T-to-C or T-to-G) conversion rate of up to 97%. The gTBE guide RNA (gRNA) component is difficult to deliver to the organelles of eukaryotic organisms, resulting in gTBE being able to only achieve the T to S base editing function of the nuclear genome, and cannot be used for organelle base editing. A research team has disclosed an organellar thymine base editor (mtTBE and cpTBE) based on UNG variants and DddAE1347A mutants; the mtTBE and cpTBE use DddA deaminase, i.e., E1347A mutant with inactivated deamination catalytic function, and have no DNA strand selectivity for base editing of target sequences, which is not conducive to improving the accuracy of base editing. Currently, there is a lack of base editors that target the T base of the organellar genome, are not dependent on deaminases, and have target DNA strand selectivity.

[0008] In summary, how to develop an efficient base editor that targets the T base of the organellar genome, is independent of deaminases, and has selectivity for the target DNA chain, avoids the off-target effects that may be caused by deaminases, and improves the accuracy of T base editing, is still a research focus and difficulty in the field of base editor technology. Summary of the invention

[0009] The purpose of the present application is to provide a new organelle genome thymine base editor, an expression vector expressing the thymine base editor, and the application of the thymine base editor and the expression vector.

[0010] This application adopts the following technical solutions:

[0011] The first aspect of the present application discloses a thymine base editor for an organelle genome, comprising a left fusion protein and a right fusion protein; the left fusion protein sequentially comprises a transit peptide, TALE-L, a DNA nickase and a DNA exonuclease, and the right fusion protein sequentially comprises a transit peptide, TALE-R and a DNA glycosylase; the transit peptide is used to guide the thymine base editor to the corresponding organelle to achieve T base editing; TALE-L and TALE-R are composed of an N-terminal functional domain, a repeating unit array and a C-terminal functional domain, wherein the repeating unit array is a specific binding sequence designed for a target sequence; the DNA glycosylase is a thymine DNA glycosylase.

[0012] It should be noted that the organellar genome thymine base editor of the present application creatively combines transit peptides, TALE arrays with engineered thymine DNA glycosylase (abbreviated TDG), DNA nickases, DNA exonucleases and other components to construct a thymine base editing system suitable for the organellar genomes of higher organisms including chloroplasts and mitochondria, enriching the technical means of base editing of the organellar genomes of higher organisms.

[0013] It should also be noted that the organellar genome thymine base editor of the present application is independent of deaminase, has target DNA chain selectivity, and has high editing efficiency and low off-target effects. It is particularly suitable for the thymine base editor system of the genome of eukaryotic organelles such as chloroplasts and mitochondria, and realizes base editing of organellar genomes from T to S, that is, T to C or T to G, avoiding the off-target effects that may be caused by deaminases and improving the accuracy of T base editing.

[0014] It can be understood that the organellar genome thymine base editor of the present application, first, uses transit peptides and TALE arrays to guide the base editor into the organellar genome target site, achieving targeted organellar genome thymine base editing; secondly, by avoiding the use of deaminases, the possible off-target effects caused by deaminases are reduced; thirdly, DNA nickases and engineered thymine DNA glycosylases are used to achieve organellar genome T to S base editing, enriching the technical means of organellar genome base editing in higher organisms. The organellar genome thymine base editor system established in this application can be applied to the study of organellar gene functions in plants, animals and human cells on the one hand, and can also be applied to agricultural biological breeding scenarios such as modifying crop organellar genes to improve agronomic traits on the other hand.

[0015] In one implementation of the present application, the transit peptide is a chloroplast transit peptide, a plant mitochondrial transit peptide or an animal mitochondrial transit peptide.

[0016] It can be understood that when the transit peptide is a chloroplast transit peptide, the organellar genome thymine base editor of the present application is a thymine base editor targeting the chloroplast genome; when the transit peptide is a plant mitochondrial transit peptide, the organellar genome thymine base editor of the present application is a thymine base editor targeting the plant mitochondrial genome; when the transit peptide is an animal mitochondrial transit peptide, the organellar genome thymine base editor of the present application is a thymine base editor targeting the animal mitochondrial genome.

[0017] In one implementation of the present application, the chloroplast transit peptide is derived from the small chain gene transit peptide of maize chloroplast ribulose bisphosphate carboxylase.

[0018] In one implementation of the present application, the plant mitochondrial transit peptide is derived from the rice Rf1a cytoplasmic male sterility restorer gene transit peptide.

[0019] In one implementation of the present application, the animal mitochondrial transit peptide is a human mitochondrial transit peptide, which is a mitochondrial transit peptide derived from the human SOD2 gene.

[0020] In one implementation of the present application, the chloroplast transit peptide is the sequence shown in SEQ ID NO.1.

[0021] In one implementation of the present application, the plant mitochondrial transit peptide is the sequence shown in SEQ ID NO.2.

[0022] In one implementation of the present application, the animal mitochondrial transit peptide is the sequence shown in SEQ ID NO.3.

[0023] It should be noted that the key to this application is to creatively combine transit peptides, TALE arrays with engineered TDG, DNA nickase and DNA exonuclease to construct a base editing system for thymine in the genome of organelles of higher organisms; the specific transit peptides of the sequences shown in SEQ ID NO.1 to SEQ ID NO.3 are only transit peptide sequences specifically used in one implementation of this application. It can be understood that under the inventive concept of this application, transit peptides of other specific sequences can also be used, and no specific limitation is made here.

[0024] In one implementation of the present application, the N-terminal functional domain is the sequence shown in SEQ ID NO.4.

[0025] In one implementation of the present application, the C-terminal functional domain is the sequence shown in SEQ ID NO.5.

[0026] It should be noted that in the TALE array, the N-terminal functional domain (NTD) and the C-terminal functional domain (CTD) are fixed amino acid sequences, such as the sequences shown in SEQ ID NO.4 and SEQ ID NO.5; the repeat unit array is designed and assembled according to the sequence of the target editing site, and the repeat unit array is assembled using the Golden Gate method, and a commercial company can be entrusted to assemble the TALE repeat units. It can be understood that the sequences shown in SEQ ID NO.4 and SEQ ID NO.5 are only the N-terminal functional domain and C-terminal functional domain specifically used in one implementation of the present application. Those skilled in the art can refer to the prior art to adjust the specific sequence, and no specific limitation is made here.

[0027] In one implementation of the present application, the DNA nickase is BspD6I nickase.

[0028] In one implementation of the present application, the BspD6I nickase is the sequence shown in SEQ ID NO.6.

[0029] In one implementation of the present application, the DNA exonuclease is Trex2 exonuclease.

[0030] In one implementation of the present application, the Trex2 exonuclease is the sequence shown in SEQ ID NO.7.

[0031] In one implementation of the present application, the DNA nickase and the DNA exonuclease are connected via a 16aa linker.

[0032] In one implementation of the present application, the 16aa linker is the sequence shown in SEQ ID NO.8.

[0033] It should be noted that BspD6I nickase and Trex2 exonuclease are only DNA nickase and DNA exonuclease with high editing efficiency specifically used in one implementation of the present application; it can be understood that on this basis, other known DNA nickases and DNA exonucleases can also be used. Similarly, the connection sequence between the DNA nickase and the DNA exonuclease can also be adjusted with reference to the prior art, and is not limited to the 16aa linker of the sequence shown in SEQ ID NO.8.

[0034] In one implementation of the present application, thymine DNA glycosylase is TDG1 or TDG2; TDG1 is an engineered mutant derived from human uracil DNA glycosylase 2, and its mutation information is Δ1-88, Y156A, A214T, Q259A and Y284D; TDG2 is an engineered mutant derived from human uracil DNA glycosylase 1, and its mutation information is Δ1-84, F85L, G107E, L142V, K175E, S237L, A255V, K259E, T266A, V274A, Y275S.

[0035] In one implementation of the present application, TDG1 is the sequence shown in SEQ ID NO.9.

[0036] In one implementation of the present application, TDG2 is the sequence shown in SEQ ID NO.10.

[0037] It should be noted that the reference for TDG1 is: Development of deaminase-free T-to-S base editor and C-to-G base editor by engineered human uracil DNA glycosylase (2024). doi: https: / / doi.org / 10.1101 / 2024.01.01.573809. The reference for TDG2 is: Ye, L., Zhao, D., Li, J. et al. Glycosylase-based base editors for efficient T-to-G and C-to-G editing in mammalian cells. Nat Biotechnol (2024). https: / / doi.org / 10.1038 / s41587-023-02050-w. The key to the present application is to creatively combine engineered thymine DNA glycosylase with transit peptide, TALE array, DNA nickase and DNA exonuclease to construct the organellar genome thymine base editor of the present application; it can be understood that under the inventive concept of the present application, it is not excluded that other engineered thymine DNA glycosylases with the same or similar functions can also be used, and no specific limitation is made here.

[0038] The second aspect of the present application discloses an expression vector for expressing the organellar genome thymine base editor of the present application.

[0039] In one implementation of the present application, the expression vector includes a vector for expressing a left-side fusion protein and a vector for expressing a right-side fusion protein.

[0040] It can be understood that the organellar genome thymine base editor of the present application includes a left fusion protein and a right fusion protein; therefore, in principle, it is preferred to express the two fusion proteins separately, that is, a vector expressing the left fusion protein and a vector expressing the right fusion protein. Of course, it is not excluded that there are other ways to express the organellar genome thymine base editor of the present application.

[0041] In one implementation of the present application, when the organellar genome thymine base editor is used for base editing of plant organelles, the expression vector is driven by a rice Ubi promoter and / or a corn Ubi promoter; when the organellar genome thymine base editor is used for base editing of animal organelles, the expression vector is driven by a human cytomegalovirus promoter.

[0042] It should be noted that the organellar genome thymine base editor of the present application can be used for genome editing of chloroplasts or mitochondria of plants, or for mitochondrial genome editing of animals, depending on the specific transit peptide used. It can be understood that the promoters specifically used in the two expression vectors are different for plants and animals. The rice Ubi promoter and the corn Ubi promoter are only promoters specifically used for plant expression vectors in one implementation of the present application, and other promoters that can be applied to plant expression vectors are not excluded. Similarly, the human cytomegalovirus promoter is also only a promoter specifically used for animal expression vectors in one implementation of the present application, and other promoters that can be applied to animal expression vectors are not excluded.

[0043] In one implementation of the present application, the expression vector has a replicon that propagates in Escherichia coli and / or Agrobacterium.

[0044] In one implementation of the present application, the expression vector has a selection marker.

[0045] In one implementation of the present application, the selection marker is a kanamycin resistance gene or an ampicillin resistance gene.

[0046] The third aspect of the present application discloses the use of the organellar genome thymine base editor of the present application or the expression vector of the present application in the preparation of breeding reagents or gene therapy reagents.

[0047] It should be noted that the organelle genome thymine base editor or expression vector of the present application can realize thymine base editing of the genomes of organelles such as plant mitochondria, chloroplasts, or animal mitochondria, that is, to realize base editing from T to C or T to G; therefore, it can not only be used for the study of organelle gene functions in plants, animals and human cells, but also can be used for modifying crop organelle genes to improve agronomic traits and other agricultural biological breeding, as well as gene therapy based on base editing.

[0048] The beneficial effects of this application are:

[0049] The organellar genome thymine base editor of the present application does not use deaminase, thus avoiding off-target effects caused by deaminase, can be used for thymine base editing in the organellar genome of eukaryotic organisms, has target DNA chain selectivity, and improves the accuracy of thymine base editing. BRIEF DESCRIPTION OF THE DRAWINGS

[0050] Figure 1 This is a schematic diagram of the organellar genome thymine base editor and its working principle in the embodiments of the present application;

[0051] Figure 2This is a schematic diagram of the structure of the supporting expression vector of the plant CPgTBE system in the embodiment of the present application;

[0052] Figure 3 This is a schematic diagram of the structure of the supporting expression vector of the plant MTgTBE system in the embodiment of the present application;

[0053] Figure 4 It is a schematic diagram of the structure of the supporting expression vector of the human MTgTBE system in the examples of this application. DETAILED DESCRIPTION

[0054] The purpose of this application is to establish a thymine base editor system that is independent of deaminase, has high editing efficiency and low off-target effects, and is suitable for the genomes of eukaryotic organelles (including chloroplasts and mitochondria), to achieve base editing of organelle genomes from T to S (i.e., T to C or T to G), to enrich the technical means of base editing of organelle genomes of higher organisms, and to expand the targeting range of base editors.

[0055] The present application establishes a deaminase-independent organellar genome thymine base editor applicable to the chloroplast and mitochondrial genomes of eukaryotes. The organellar genome thymine base editors of the present application include: a glycosylase-based chloroplast thymine base editor (Chloroplast glycosylase-based Thymine Base Editor, CPgTBE) and a glycosylase-based mitochondrial thymine base editor (Mitochondia glycosylase-based Thymine Base Editor, MTgTBE). CPgTBE and MTgTBE use similar fusion protein architectures, both consisting of two fusion proteins. The left fusion protein contains four key components, including a transit peptide, TALE-L, a DNA nickase (such as BspD6I nickase), and a DNA exonuclease (such as Trex2 exonuclease). The right fusion protein contains three key components, including a transit peptide, TALE-R, and a DNA glycosylase, such as Figure 1 shown.

[0056] The basic working principle of CPgTBE and MTgTBE described in the present application is: a DNA nickase (such as BspD6I nickase) cuts one of the DNA double strands at the target site and generates a nick, a DNA exonuclease (such as Trex2 exonuclease) recognizes the nick region and digests the nicked DNA strand, thereby exposing a short single-stranded DNA (ssDNA) fragment; a DNA glycosylase uses ssDNA as a substrate to remove the T base at the target editing site to generate an apyrimidine site (AP site), and the AP site will be repaired by translesion synthesis (TLS) and / or DNA replication, thereby resulting in base editing from T to S, such as Figure 1shown.

[0057] The function of the transit peptide in the fusion protein of CPgTBE and MTgTBE is to guide the base editor to the corresponding organelle to realize T base editing. In one implementation of the present application, three transit peptides are provided. According to three application scenarios such as targeting chloroplasts, plant mitochondria and human mitochondrial genomes, three corresponding transit peptides are selected, that is, chloroplast transit peptides are selected when the chloroplast genome is targeted for editing, plant mitochondrial transit peptides are selected when the plant mitochondrial genome is targeted for editing, and human mitochondrial transit peptides are selected when the human and animal mitochondrial genomes are targeted for editing. The chloroplast transit peptide is derived from the small chain gene transit peptide of the ribulose bisphosphate carboxylase in the chloroplast of corn, the plant mitochondrial transit peptide is derived from the rice Rf1a cytoplasmic male sterility restoration gene transit peptide, and the human mitochondrial transit peptide is derived from the mitochondrial transit peptide of the human SOD2 gene.

[0058] The function of the TALE array in the CPgTBE and MTgTBE fusion proteins, namely TALE-L and TALE-R, is to accurately carry components such as DNA nickase, DNA exonuclease and DNA glycosylase to the target editing site of the genome. Since the gRNA component of CRISPR / Cas9 cannot enter the organelle, and TALE can enter the organelle under the guidance of the signal peptide and accurately locate the target editing site of the organelle genome, this application uses the TALE array as the DNA binding domain component. TALE consists of three parts: the N-terminal functional domain (NTD), the repeat unit array and the C-terminal functional domain (CTD). The N-terminal functional domain (NTD) and the C-terminal functional domain (CTD) are fixed amino acid sequences. The repeat unit array is designed and assembled according to the sequence of the target editing site. The repeat unit is assembled using the Golden Gate method, and commercial companies can be commissioned to assemble the TALE repeat units.

[0059] The left fusion proteins of CPgTBE and MTgTBE have a DNA nickase (such as BspD6I nickase) fused to the C-terminus of TALE-L, e.g. Figure 1 As shown. The present application uses a partial functional domain of the Nt.BspD6I nickase derived from Bacillus. Nt.BspD6I can form a heterodimer with BspD6I (small subunit, 20 kDa) and act as a restriction endonuclease called R.BspD6I 25. The Nt.BspD6I(C) used in the present application for fusion with TALE is only the C-terminal cleavage domain, i.e., amino acids 382-604, which has a very low chain preference and can cut and produce a nick at the target DNA editing site. The DNA nickase selected is Nt.BspD6I(C), but is not limited to Nt.BspD6I(C).

[0060] A DNA exonuclease (such as Trex2 exonuclease) is also fused to the C-terminus of the left fusion protein DNA nickase. Figure 1 As shown. Trex2 is a 3'→5' digestion-preferring exonuclease. DNA nickase and Trex2 are connected by a 16aa linker. The function of Trex2 is to digest the nicked DNA at the DNA nick produced by the DNA nickase, thereby exposing a short ssDNA fragment at the target DNA editing site.

[0061] A DNA glycosylase is also fused to the C-terminus of the right fusion protein TALE-R, such as Figure 1 As shown. This application configures the corresponding DNA glycosylase according to the function of the base editor. CPgTBE and MTgTBE are configured with thymine DNA glycosylase (TDG). The function of TDG is to remove the T base of the ssDNA exposed at the target editing site to generate a pyrimidine-free site (AP site). The AP site will be repaired by translesion synthesis (TLS) and / or DNA replication, resulting in base editing from T to S, such as Figure 1 As shown. The present application provides two TDGs with excision of canonical thymine bases, namely TDG1 and TDG2. TDG1 is an engineered mutant derived from human uracil DNA glycosylase 2 (UNG2) (Δ1-88, Y156A, A214T, Q259A, Y284D); and TDG2 is an engineered mutant derived from human uracil DNA glycosylase 1 (UNG1) (Δ1-84, F85L, G107E, L142V, K175E, S237L, A255V, K259E, T266A, V274A, Y275S). TDG1 or TDG2 can be selected according to actual applications.

[0062] The present application provides bacterial and eukaryotic binary expression vectors of the CPgTBE and MTgTBE systems. The supporting vectors of the plant CPgTBE system include pgTBEp, pCPgTBE-L and pCPgTBE-R, such as Figure 2 The supporting vectors of the plant MTgTBE system include pgTBEp, pMTgTBE-L and pMTgTBE-R, as shown in Figure 3 As shown. The supporting vectors of the human MTgTBE system include pMTgTBE-hL and pMTgTBE-hR, as shown Figure 4 shown.

[0063] The expression of plant CPgTBE and MTgTBE is driven by the rice Ubi promoter (rUbi) and the maize Ubi promoter (ZmUbi), and the terminator is the Nos terminator (NosT). Human MTgTBE is driven by the human cytomegalovirus (CMV) promoter. The pgTBEp plasmid vector has a replicon that can be propagated in Escherichia coli and Agrobacterium, as well as a selection marker kanamycin resistance gene (Kanamycin resistance provided by aminoglycoside phosphotransferasegene, KanR). pMTgTBE-hL and pMTgTBE-hR plasmid vectors have a replicon that can be propagated in Escherichia coli, as well as a selection marker ampicillin resistance gene, ampicillin resistance provided by β-lactamase gene, AmpR.

[0064] The present application provides a method for constructing the above-mentioned organelle genome base editing system.

[0065] Plant CPgTBE system construction method: TALE-L and TALE-R repeat unit arrays were designed according to the sequences on both sides of the target editing site of the chloroplast genome of interest, and the TALE repeat units were commissioned to be assembled by commercial companies. The assembled TALE-L and TALE-R repeat unit arrays were inserted into the pCPgTBE-L and pCPgTBE-R vectors through the BsaI site, respectively. The gene fragments of the transit peptide, TALE-L, DNA nickase, and Trex2 exonuclease fusion protein of pCPgTBE-L were cloned into the ZmUbi-NosT expression cassette of the pgTBEp vector through the KpnI-SacI restriction endonuclease site; the transit peptide, TALE-R, and DNA glycosylase fusion protein expression cassettes of pCPgTBE-R (driven by rUbi) replaced the toxic protein marker ccdB expression cassette of the pgTBEp vector through the LR Gateway. Finally, the pgTBEp vector integrated two expression cassettes: transit peptide, TALE-L, DNA nickase, Trex2 fusion protein and transit peptide, TALE-R, DNA glycosylase fusion protein, for plant genetic transformation.

[0066] The method for constructing the plant MTgTBE system is similar to the above-mentioned "method for constructing the plant CPgTBE system". It is only necessary to replace pCPgTBE-L with the corresponding pMTgTBE-L, and replace pCPgTBE-R with the corresponding pMTgTBE-R. Other operations are the same.

[0067] Method for constructing the human MTgTBE system: Design TALE-L and TALE-R repeat unit arrays according to the sequences on both sides of the target editing site of the mitochondrial genome of interest, and entrust a commercial company to assemble the TALE repeat units. The assembled TALE-L and TALE-R repeat unit arrays are inserted into the pMTgTBE-hL and pMTgTBE-hR vectors through the BsaI site, respectively. pMTgTBE-hL contains the gene fragments of the transit peptide, TALE-L, BspD6I, and Trex2 fusion protein in the CMV expression cassette, and pMTgTBE-R contains the transit peptide, TALE-R, and glycosylase fusion protein expression cassette for cell infection and transformation.

[0068] The present application also provides an application method of the above-mentioned organelle genome base editing system. Specifically, after selecting the target position sequence of mitochondrial or chloroplast DNA of plants such as rice and corn, as well as the target position sequence of human mitochondrial DNA, TALE repeat units are assembled and the corresponding vector construction is completed. The vector can transform Agrobacterium, and the positive Agrobacterium strain can be further transformed into plants by Agrobacterium infection; or the plasmid vector can be directly transformed into plants by gene gun transformation method, so that the target site sequence can achieve TS base editing.

[0069] The application method of the base editing system of the present application also includes: extracting the transformed plant or human organelle DNA, then performing PCR amplification using specific primers for the target, using the PCR products of the organelle DNA to construct a high-throughput second-generation DNA sequencing library, and performing high-throughput second-generation DNA sequencing.

[0070] Among them, the organellar DNA targets of a certain species include but are not limited to PsbC, Nad7 and Cox3 targets.

[0071] The present application is further described in detail below by specific examples. The following examples are only used to further illustrate the present application and should not be construed as limiting the present application. Unless otherwise specified, the methods for plasmid or strain construction in the present application are all based on the Molecular Cloning Experiment Guide (4th edition).

[0072] Example

[0073] The experimental method includes the following steps:

[0074] 1) Constructing an expression vector: Design TALE target sequences on both sides of the target base editing site. The previous base at the 5' end of the TALE target sequence must be a T base, and the TALE target sequence length is in the range of 12-24 bp. At the same time, the distance between the 3' end of the TALE target sequence and the target base editing site is in the range of 3-20 bp, and the editing efficiency is high. After the TALE target sequence is designed and determined, the TALE repeat unit array is assembled according to the TALE target sequence. Then the TALE repeat unit array is cloned into the corresponding expression vector provided by the present invention through the BsaI restriction site.

[0075] 2) Plant expression vectors use Agrobacterium to transform plant tissues; while human cell expression vectors transform the cell line HEK293T.

[0076] 3) Extraction and amplification of genomic DNA: Extract the genomic DNA of transformed cells and then perform PCR amplification using specific primers for the target editing site.

[0077] 4) High-throughput second-generation DNA sequencing of PCR products of genomic DNA; constructing a high-throughput second-generation DNA sequencing library using PCR products of genomic DNA, and performing high-throughput second-generation DNA sequencing.

[0078] 1. Base editing of the rice chloroplast PsbC gene using the plant CPgTBE system

[0079] 1) Reagents

[0080] Primers were synthesized by Sangon Biotech (Shanghai) Co., Ltd. according to conventional methods; plasmid sequencing was entrusted to Sangon Biotech (Shanghai) Co., Ltd.; KpnI, SacI, BsaI restriction endonucleases, DNA ligase (T4 DNAligase), and high-fidelity DNA polymerase were purchased from NEB; LR Gateway Enzymemix was purchased from Thermo Fisher Scientific; ampicillin, kanamycin sulfate, and rifampicin were purchased from Beijing Solebao Technology Co., Ltd.; plasmid mini-extraction kit, DNA gel recovery kit, and high-efficiency plant genomic DNA extraction kit were purchased from Tiangen Biochemical Technology Co., Ltd.; DB3.1 and Trans1-T1 Escherichia coli competent cells, and EHA105 Agrobacterium competent cells were purchased from Shanghai Weidi Biotechnology Co., Ltd.; plasmids pSK and pCAMBIA1300 were purchased from Sangon Biotechnology (Shanghai) Co., Ltd.; gene synthesis was commissioned to Sangon Biotechnology (Shanghai) Co., Ltd.; TALE repeat unit arrays were commissioned to Guangzhou Yijin Biotechnology Co., Ltd. for assembly; rice genetic transformation experiments were commissioned to Wuhan Boyuan Biotechnology Co., Ltd.; QuickExtractTM genomic DNA extraction reagents and high-throughput DNA second-generation sequencing library construction kit TmSeqChIPLibaryPreparation Kit were purchased from Illumina.

[0081] 2) Vector construction

[0082] The pCPgTBE-L and pCPgTBE-R vectors use the pSK plasmid as the starting backbone, and the pgTBEp vector uses the pCAMBIA1300 plasmid as the starting backbone. The synthesis and cloning of the ZmUbi promoter, aatL, NTD, ccdB and other element fragments were commissioned to Sangon Biotech (Shanghai) Co., Ltd.

[0083] 3) TALE target sequence design and vector assembly

[0084] TALE-L and TALE-R repeat unit arrays were designed according to the sequences on both sides of the PsbC target editing site of the chloroplast gene of interest. According to the rules that the four TALE repeat units NI, NG, NN and HD recognize the nucleotides "A", "T", "G" and "C", respectively, a commercial company was commissioned to assemble the TALE repeat units. The assembled TALE-L and TALE-R repeat unit arrays were inserted into the pCPgTBE-L and pCPgTBE-R vectors through the BsaI site, respectively, and transformed into Trans1-T1 Escherichia coli and cultured on ampicillin plates. The TALE repeat unit arrays of pCPgTBE-L and pCPgTBE-R were sequenced and confirmed by sequencing primers NTD-F and CTD-R.

[0085] Among them, the TALE-L repeat unit array is the sequence shown in SEQ ID NO.11, the TALE-R repeat unit array is the sequence shown in SEQ ID NO.12, the sequencing primer NTD-F is the sequence shown in SEQ ID NO.13, and CTD-R is the sequence shown in SEQ ID NO.14.

[0086] SEQ ID NO.11: 5'-CATGAAAATCTTATATTC-3'

[0087] SEQ ID NO.12: 5'-AAAGAGCGTTTCCACGTGGT-3'

[0088] SEQ ID NO.13: 5'-CACCACTCCAGTTGGACACAG-3'

[0089] SEQ ID NO.14: 5'-TAGGAACGCGGTGGGATGTG-3'

[0090] The PsbC target site editing chain is the sequence shown in SEQ ID NO.27.

[0091] SEQ ID NO.27: 5'-AGAACCTCCTCAGG-3'

[0092] pCPgTBE-L cloned the gene fragments of transit peptide, TALE-L, BspD6I nickase, and Trex2 exonuclease fusion protein into the ZmUbi-NosT expression cassette of the pgTBEp vector through the KpnI-SacI restriction endonuclease site, transformed into DB3.1 Escherichia coli, and cultured on kanamycin sulfate plates; then the transit peptide, TALE-R, and DNA glycosylase fusion protein expression cassette of pCPgTBE-R were driven by rUbi, replaced the toxic protein marker ccdB expression cassette of the pgTBEp vector through LRGateway, transformed into Trans1-T1 Escherichia coli, and cultured on kanamycin sulfate plates. Finally, the pgTBEp vector integrated the fusion protein of transit peptide, TALE-L, BspD6I nickase, Trex2 exonuclease and the two expression cassettes of transit peptide, TALE-R, and DNA glycosylase fusion protein, recorded as pCPgTBE-PsbC, and used for plant genetic transformation.

[0093] Among them, the transit peptide is the sequence shown in SEQ ID NO.1, the N-terminal functional domains of TALE-L and TALE-R are the sequence shown in SEQ ID NO.4, the C-terminal functional domains of TALE-L and TALE-R are the sequence shown in SEQ ID NO.5, the BspD6I nickase is the sequence shown in SEQID NO.6, the Trex2 exonuclease is the sequence shown in SEQ ID NO.7, and the BspD6I nickase and Trex2 exonuclease are connected by a 16aa linker, and the 16aa linker is the sequence shown in SEQID NO.8.

[0094] The DNA glycosylase in this example can be TDG1 or TDG2, and TDG1 is specifically used in this example. TDG1 is the sequence shown in SEQ ID NO.9, and TDG2 is the sequence shown in SEQ ID NO.10.

[0095] SEQ ID NO.1:

[0096] APTVMMASSATAVAPFQGLKSAASLPVARRSTRSLGNVSNGGRIRCMQ

[0097] SEQ ID NO.4:

[0098] DLRTLGYSQQQQEKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVTYQDIIRALPEATHEDIVGVGKQWSGARALEALLTEAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVH

[0099] SEQ ID NO.5: RPALDAVKKGLPHAPELIRRINRRIPERTSHRVP

[0100] SEQ ID NO.6:

[0101] RQLEEVIDLLEVYHEKKNVIEEKIKARFIANKNTVFEWLTWNGFIILGNALEYKNNFVIDEELQPVTHAAGNQPDMEIIYEDFIVLGEVTTSKGATQFKMESEPVTRHYLN KKKELEKQGVEKELYCLFIAPEINKNTFEEFMKYNIVQNTRIIPLSLKQFNMLLMVQKKLIEKGRRLSSYDIKNLMVSLYRTTIECERKYTQIKAGLEETLNNWVVDKEVRF

[0102] SEQ ID NO.7:

[0103] MSEPPRAETFVFLDLEATGLPNMDPEIAEISLFAVHRSSLENPERDDSGSLVLPRVLDKLTLCMCPERPFTAKASEITGLSSESLMHCGKAGFNGAVVRTLQGFLSRQEGPICLVAHNGFDYDFPLLCTELQRLGAHLPQDTVCLDTLPALRGLDRAHSHGTRAQGRKSYSLASLFHRYFQAEPSAAHSAEGDVHTLLLIFLHRAPELLAWADEQARSWAHIEPMYVPPDGPSLEA

[0104] SEQ ID NO.8: SGSETPGTSESATPES

[0105] SEQ ID NO.9:

[0106] NVPVGFGESWKKHLSGEFGKPYFIKLMGFVAEERKHYTVYPPPHQVFTWTQMCDIKDVKVVILGQDPAHGPNQAHGLCFSVQRPVPPPPSLENIYKELSTDIEDFVHPGHGDLSGWAKQGVLLLNTVLTVRAHQANSHKERGWEQFTDAVVSWLNQNSNGLVFLLWGSYAAKKGSAIDRKRHHVLQTAHPSPLSVDRGFFGCRHFSKTNELLQKSGKKPIDWKEL

[0107] SEQ ID NO.10:

[0108] LGESWKKHLSGEFGKPYFIKLMEFVAEERKHYTVYPPPHQVFTWTQMCDIKDVKVVIVGQDPAHGPNQAHGLCFSVQRPVPPPPSLENIYEELSTDIEDFVHPGHGDLSGWAKQGVLLLNAVLTVRAHQANSHKERGWEQFTDAVVSWLNQNLNGLVFLLWGSYAQKKGSVIDRERHHVLQAAHPSPLSASRGFFGCRHFSKTNELLQKSGKKPIDWKEL

[0109] 4) Rice genetic transformation

[0110] Extract pCPgTBE-PsbC positive clone plasmid, take 50ng to transform EHA105 Agrobacterium competent cells, spread on LB bacterial culture plate, containing 50μg / mL kanamycin sulfate and 50μg / mL rifampicin, and culture at 28℃ for 36h to obtain single colonies. The positive Agrobacterium colony was entrusted to Wuhan Boyuan Biotechnology Co., Ltd. for rice callus infection and subsequent resistant callus (screening antibiotic is hygromycin) and callus regeneration to obtain transgenic plants. Transgenic plants show yellowing or whitening of leaves.

[0111] 5) Identification of transgenic plants and analysis of target site gene editing efficiency

[0112] The leaves of the transgenic plants were taken and the total genomic DNA was extracted using an efficient plant genomic DNA extraction kit. Primers ZmUbi-F and NTD-R were used to identify whether the transgenic plants were positive (i.e., containing the pCPgTBE-PsbC transgenic fragment). Primers PsbC-F and PsbC-R were used to amplify the chloroplast DNA fragment containing the target site sequence for analysis of the target site gene editing efficiency.

[0113] Among them, ZmUbi-F is the sequence shown in SEQ ID NO.15, NTD-R is the sequence shown in SEQ ID NO.16, PsbC-F is the sequence shown in SEQ ID NO.17, and PsbC-R is the sequence shown in SEQ ID NO.18.

[0114] SEQ ID NO.15: 5'-TTTAGCCCTGCCTTCATACGC-3'

[0115] SEQ ID NO.16: 5'-CTGGCTGAGAGCAACGATGTG-3'

[0116] SEQ ID NO.17: 5'-CAATGGTCACCGCTAATCGCT-3'

[0117] SEQ ID NO.18: 5'-TTCTGGTACGAAATGGGCCAC-3'

[0118] The PCR system is as follows:

[0119] Phusion (NEB, M0535L) 1μL; 5×buffer (NEB, B0518S) 4μL; ForwardPrimer (5μM) 1μL; Reverse Primer (5μM) 1μL; Template 50ng; RNase-free water was added to 50μL.

[0120] The PCR program was as follows: 95°C, 2 min; then 33 cycles: 95°C, 15 sec, 60°C, 30 sec, 72°C, 1 min; after the cycle, 72°C, 3 min.

[0121] The PCR products of PsbC-F and PsbC-R primers were used to prepare high-throughput sequencing libraries for DNA-seq. Specifically, the concentration and purity of PCR products were first checked using Qubit Fluorometer and Aglient Bioanalyzer 2100 respectively; for samples that passed the quality inspection, different PCR products were added with different biotin-labeled barcodes using the Illumina official kit TruSeq ChIP Sample Preparation Kit, and PCR amplification and enrichment were performed to complete the preparation of sequencing libraries, and the concentration and fragment size of the constructed libraries were checked; finally, high-throughput sequencing was performed using the Illumina HiSeq 2500 sequencer.

[0122] The results of high-throughput sequencing showed that the efficiency of converting the two target T bases in the editing chain of the PsbC target site into C bases reached 56% and 64%, respectively, and the efficiency of converting them into G bases reached 17% and 15%, respectively.

[0123] 2. Base editing of rice mitochondrial Nad7 gene using the plant MTgTBE system

[0124] 1) Reagents

[0125] Same as “1. Base editing of rice chloroplast PsbC gene using plant CPgTBE system”.

[0126] 2) Vector construction

[0127] The pMTgTBE-L and pMTgTBE-R vectors use the pSK plasmid as the starting backbone, and the pgTBEp vector uses the pCAMBIA1300 plasmid as the starting backbone. The synthesis and cloning of the ZmUbi promoter, aatL, NTD, ccdB and other element fragments were commissioned to Sangon Biotech (Shanghai) Co., Ltd.

[0128] 3) TALE target sequence design and vector assembly

[0129] TALE-L and TALE-R repeat unit arrays were designed according to the sequences on both sides of the target editing site of the mitochondrial gene Nad7 of interest. According to the rules that the four TALE repeat units NI, NG, NN and HD recognize the nucleotides "A", "T", "G" and "C", respectively, a commercial company was commissioned to assemble the TALE repeat units. The assembled TALE-L and TALE-R repeat unit arrays were inserted into the pMTgTBE-L and pMTgTBE-R vectors (transformed into Trans1-T1 Escherichia coli and cultured on ampicillin plates) through the BsaI site. The TALE repeat unit arrays of pMTgTBE-L and pMTgTBE-R can be sequenced and confirmed by sequencing primers NTD-F and CTD-R.

[0130] Among them, the TALE-L repeat unit array is the sequence shown in SEQ ID NO.19, the TALE-R repeat unit array is the sequence shown in SEQID NO.20, and the sequencing primers NTD-F and CTD-R are the same as "1. Base editing of rice chloroplast PsbC gene using plant CPgTBE system".

[0131] SEQ ID NO.19: 5'-TTGACTGGGCTTACGCACAT-3'

[0132] SEQ ID NO. 20: 5'-GGGGTGAGCTGAGGGGGGAC-3'.

[0133] The Nad7 target site editing chain is the sequence shown in SEQ ID NO.28.

[0134] SEQ ID NO.28: 5'-AGCGTAAGTGAGCGA-3'

[0135] pMTgTBE-L cloned the gene fragments of transit peptide, TALE-L, BspD6I, and Trex2 fusion protein into the ZmUbi-NosT expression cassette of the pgTBEp vector through the KpnI-SacI restriction endonuclease site (transformed into DB3.1 Escherichia coli and cultured on kanamycin sulfate plates); then the transit peptide, TALE-R, and DNA glycosylase fusion protein expression cassettes of pMTgTBE-R (driven by rUbi) replaced the toxic protein marker ccdB expression cassette of the pgTBEp vector through LR Gateway (transformed into Trans1-T1 Escherichia coli and cultured on kanamycin sulfate plates). Finally, the pgTBEp vector integrated the two expression cassettes of transit peptide, TALE-L, DNA nickase, Trex2 fusion protein and transit peptide, TALE-R, and DNA glycosylase fusion protein, recorded as pMTgTBE-Nad7, and used for plant genetic transformation.

[0136] Among them, the transit peptide is the sequence shown in SEQ ID NO.2, the N-terminal functional domain, C-terminal functional domain of TALE-L and TALE-R, as well as BspD6I nickase, Trex2 exonuclease, and the connecting linker of BspD6I nickase and Trex2 exonuclease are the same as "1. Base editing of rice chloroplast PsbC gene using plant CPgTBE system".

[0137] SEQ ID NO.2:

[0138] ARRAASRAVGALRSDGSIQGRGGRAGGSGAEDARHVFDELLRRGRGASIYGLNRALADVARDSPAAAVSRYNR

[0139] 4) Rice genetic transformation

[0140] The genetic transformation of rice with pMTgTBE-Nad7 was the same as “1. Base editing of rice chloroplast PsbC gene using plant CPgTBE system”.

[0141] 5) Identification of transgenic plants and analysis of target site gene editing efficiency

[0142] The methods for transgenic plant identification and target site gene editing efficiency analysis are the same as those in "I. Base editing of rice chloroplast PsbC gene using plant CPgTBE system", except that the sequencing fragment amplification primers are changed to Nad7-F and Nad7-R. Nad7-F is the sequence shown in SEQ ID NO.21, and Nad7-R is the sequence shown in SEQ ID NO.22.

[0143] SEQ ID NO.21: 5'-GAGACTTCCTCTACCCACATC-3'

[0144] SEQ ID NO.22: 5'-TACTGTCACTGCACAGCAAGC-3'

[0145] The results of high-throughput sequencing showed that the efficiency of converting the two target T bases in the editing chain of the Nad7 target site into C bases reached 59% and 63%, respectively, and the efficiency of converting them into G bases reached 21% and 23%, respectively.

[0146] 3. Base editing of the mitochondrial Cox3 gene in human cells using the human MTgTBE system

[0147] 1. Experimental Materials

[0148] 1) Reagents

[0149] Primers were synthesized by Sangon Biotech (Shanghai) Co., Ltd. according to conventional methods; plasmid sequencing was commissioned by Sangon Biotech (Shanghai) Co., Ltd.; vector plasmid pCMV was purchased from Yunzhou Biotechnology (Guangzhou) Co., Ltd.; gene synthesis was commissioned by Yunzhou Biotechnology (Guangzhou) Co., Ltd.; TALE repeat unit array was assembled by Guangzhou Yijin Biotechnology Co., Ltd.; KpnI, SacI, BsaI restriction endonucleases, DNA ligase (T4 DNA ligase) high-fidelity DNA polymerase were purchased from NEB; DB3.1 and Trans1-T1 Escherichia coli competent cells were purchased from Shanghai Weidi Biotechnology Co., Ltd.; ampicillin and kanamycin sulfate were purchased from Beijing Solebow Technology Co., Ltd.; EndoFree plasmid kit was purchased from Qiagen; GeneJET gel extraction kit was purchased from Thermo Scientific; mycoplasma detection kit was purchased from TransGen Biotech Company; 48-well poly-d-lysine coated plates were purchased from Corning; PolyplusTransfection cell transfection kit was purchased from ANNORON; proteinase K and 1×Dulbecco's PBS were purchased from Thermo Fisher Scientific; QuickExtractTM genomic DNA extraction reagent and high-throughput DNA second-generation sequencing library construction kit TmSeqChIPLibary Preparation Kit were purchased from Illumina.

[0150] 2) Cell line: HEK293T (purchased from the Cell Bank of the Chinese Academy of Sciences)

[0151] 2. Experimental Methods

[0152] 1) Vector construction

[0153] The pMTgTBE-hL and pMTgTBE-hR vectors use the pCMV plasmid as the starting backbone, and the synthesis and cloning of SOD2 transport peptide, Trex2, ccdB and other element fragments are all completed by commercial companies.

[0154] 2) TALE target sequence design and vector assembly

[0155] TALE-L and TALE-R repeat unit arrays were designed according to the sequences on both sides of the Cox3 target editing site of the mitochondrial gene of interest. According to the rules that the four TALE repeat units NI, NG, NN and HD recognize the nucleotides "A", "T", "G" and "C", respectively, a commercial company was commissioned to assemble the TALE repeat units. The pMTgTBE-hL and pMTgTBE-hR vectors were propagated by DB3.1 Escherichia coli, and plasmid DNA was extracted using a plasmid kit. The assembled TALE-L and TALE-R repeat unit arrays were inserted into the pMTgTBE-hL and pMTgTBE-hR vectors (transformed into Trans1-T1 Escherichia coli and cultured on ampicillin plates) through the BsaI site. The TALE repeat unit arrays of pMTgTBE-hL and pMTgTBE-hR can be sequenced and confirmed by sequencing primers NTD-F and CTD-R. pMTgTBE-hL contains the gene fragments of transit peptide, TALE-L, BspD6I, and Trex2 fusion protein in a CMV expression cassette, recorded as pMTgTBE-Cox3L, and pMTgTBE-hR contains the expression cassette of transit peptide, TALE-R, and glycosylase fusion protein, recorded as pMTgTBE-Cox3R, which are used for cell infection and transformation.

[0156] Among them, the TALE-L repeat unit array is the sequence shown in SEQ ID NO.23, the TALE-R repeat unit array is the sequence shown in SEQID NO.24, and the sequencing primers NTD-F and CTD-R are the same as "1. Base editing of rice chloroplast PsbC gene using plant CPgTBE system".

[0157] SEQ ID NO.23: 5'-TTCACTTCCACTCCATAA-3'

[0158] SEQ ID NO.24: 5'-GGTTAGTGTGTTGGTTAGTA-3'

[0159] The transit peptide is the sequence shown in SEQ ID NO.3. The N-terminal functional domain, C-terminal functional domain, BspD6I nickase, Trex2 exonuclease, and the connecting linker of BspD6I nickase and Trex2 exonuclease of TALE-L and TALE-R are the same as "1. Base editing of rice chloroplast PsbC gene using plant CPgTBE system".

[0160] SEQ ID NO.3: LSRAVCGTSRQLAPVLGYLGSRQKHSLPD

[0161] The Cox3 target site editing chain is the sequence shown in SEQ ID NO.29.

[0162] SEQ ID NO.29: 5'-GGCCTAGTATGAGGAGCG-3'

[0163] 3) Eukaryotic cell transfection

[0164] The pTBE-Cox3 plasmid used for transfection of HEK293T cell line was extracted and purified using EndoFree Plasmid Kit (Qiagen).

[0165] HEK293T cells were cultured in DMEM (Gibco) supplemented with 10% (vol / vol) fetal bovine serum (FBS, Gibco) and 1% (vol / vol) penicillin-streptomycin (Gibco) in a humidified incubator at 37°C with 5% CO2. All cells were routinely tested for mycoplasma contamination using a mycoplasma detection kit (TransGen Biotech). A total of 40,000 cells per well were seeded into a 48-well poly-d-lysine coated plate without antibiotics. After 16-24 hours, HEK293T cells were transfected with 1 μL jetPRIME transfection reagent (PolyplusTransfection Kit) and 400 ng pMTgTBE-Cox3L and pMTgTBE-Cox3R plasmids per well to a cell confluence of 60-80%. Cells were washed with PBS 72 hours after transfection and DNA was extracted.

[0166] 4) Genomic DNA extraction and PCR amplification

[0167] After washing the cells once with 1× Dulbecco's PBS, genomic DNA was extracted by adding 100 μL of freshly prepared lysis buffer (10 mM Tris-HCl (pH 8.0), 0.05% SDS, and 25 μg / mL proteinase K) directly to the 48-well culture. The mixture was incubated at 37°C for 60 minutes and then at 80°C for 20 minutes.

[0168] The extracted genomic DNA was amplified by PCR using the following primers Cox3-F and Cox3-R, and the PCR product was recovered by gel excision using the GeneJET gel extraction kit according to the reagent operating instructions for subsequent construction of a high-throughput second-generation DNA sequencing library. Wherein, Cox3-F is the sequence shown in SEQ ID NO.25, and Cox3-R is the sequence shown in SEQ ID NO.26.

[0169] SEQ ID NO.25: 5'-GGAAGCGCCACCCTAGCAAT-3'

[0170] SEQ ID NO.26: 5'-GGCCAGTGCCCTCCTAATTG-3'

[0171] Amplify genomic DNA using the following PCR system:

[0172] Phusion (NEB, M0535L) 1μL; 5×buffer (NEB, B0518S) 4μL; ForwardPrimer (5μM) 1μL; Reverse Primer (5μM) 1μL; Template 10ng; RNase-free water is added to 50μL.

[0173] The PCR program is as follows:

[0174] 95℃, 2min; then enter 30 cycles: 95℃, 15sec, 55℃, 15sec, 72℃, 30sec; after the cycle, 72℃, 3min.

[0175] 5) High-throughput second-generation DNA sequencing

[0176] The PCR products were used to prepare high-throughput sequencing libraries for DNA-seq. Specifically, the concentration and purity of the PCR products were first checked using Qubit Fluorometer and Aglient Bioanalyzer 2100 respectively; the samples that passed the quality inspection were then fragmented using Covaris S220 ultrasonic DNA crusher; then, different PCR products were added with different biotin-labeled barcodes using the Illumina official kit TruSeq ChIP Sample Preparation Kit, and PCR amplification and enrichment were performed to complete the preparation of the sequencing library, and the concentration and fragment size of the constructed library were checked; finally, the Illumina HiSeq 2500 sequencer was used for high-throughput sequencing.

[0177] The results of high-throughput sequencing showed that the efficiency of converting the three target T bases in the Cox3 target site editing chain into C bases reached 48%, 69% and 70%, respectively, and the efficiency of converting them into G bases reached 18%, 25% and 22%, respectively.

[0178] The above test results show that the organellar genome thymine base editor of the present application is independent of deaminase and can edit the genome thymine bases from T to S, that is, T to C or T to G, in the mitochondria and chloroplasts of plants and the mitochondria of animals. It fills the gap in the technology and tools for thymine base editing of the organellar genome of eukaryotic organisms and expands the targeting range of base editors.

[0179] The above contents are further detailed descriptions of the present application in combination with specific implementation methods, and it cannot be determined that the specific implementation of the present application is limited to these descriptions. For ordinary technicians in the technical field to which the present application belongs, several simple deductions or substitutions can be made without departing from the concept of the present application.

Claims

1. A thymine base editor for an organellar genome, characterized in that: Includes left fusion protein and right fusion protein; The left fusion protein sequentially comprises a transit peptide, TALE-L, a DNA nickase, and a DNA exonuclease, and the right fusion protein sequentially comprises a transit peptide, a TALE-R, and a DNA glycosylase; The transit peptide is used to guide the thymine base editor to the corresponding organelle to achieve T base editing; The TALE-L and TALE-R are composed of an N-terminal functional domain, a repeating unit array, and a C-terminal functional domain, wherein the repeating unit array is a specific binding sequence designed for the target sequence; The DNA glycosylase is thymine DNA glycosylase.

2. The organellar genome thymine base editor according to claim 1, characterized in that: The transit peptide is a chloroplast transit peptide, a plant mitochondrial transit peptide or an animal mitochondrial transit peptide; Preferably, the chloroplast transit peptide is derived from the small chain gene transit peptide of maize chloroplast ribulose bisphosphate carboxylase; Preferably, the plant mitochondrial transit peptide is derived from the rice Rf1a cytoplasmic male sterility restorer gene transit peptide; Preferably, the animal mitochondrial transit peptide is a human mitochondrial transit peptide, which is a mitochondrial transit peptide derived from the human SOD2 gene.

3. The organellar genome thymidine base editor according to claim 2, characterized in that: The chloroplast transit peptide is the sequence shown in SEQ ID NO.1; Preferably, the plant mitochondrial transit peptide is the sequence shown in SEQ ID NO.2; Preferably, the animal mitochondrial transit peptide is the sequence shown in SEQ ID NO.

3.

4. The organellar genome thymine base editor according to claim 1, characterized in that: The N-terminal functional domain is the sequence shown in SEQ ID NO.4; Preferably, the C-terminal functional domain is the sequence shown in SEQ ID NO.

5.

5. The organellar genome thymidine base editor according to claim 1, characterized in that: The DNA nickase is BspD6I nickase; Preferably, the BspD6I nickase is the sequence shown in SEQ ID NO.6; Preferably, the DNA exonuclease is Trex2 exonuclease; Preferably, the Trex2 exonuclease is the sequence shown in SEQ ID NO.7; Preferably, the DNA nickase and the DNA exonuclease are connected via a 16aa linker; Preferably, the 16aa linker is the sequence shown in SEQ ID NO.

8.

6. The organellar genome thymidine base editor according to claim 1, characterized in that: The thymine DNA glycosylase is TDG1 or TDG2; The TDG1 is an engineered mutant derived from human uracil DNA glycosylase 2, and its mutation information is Δ1-88, Y156A, A214T, Q259A and Y284D; The TDG2 is an engineered mutant derived from human uracil DNA glycosylase 1, and its mutation information is Δ1-84, F85L, G107E, L142V, K175E, S237L, A255V, K259E, T266A, V274A, Y275S; Preferably, the TDG1 is the sequence shown in SEQ ID NO.9; Preferably, the TDG2 is the sequence shown in SEQ ID NO.

10.

7. An expression vector expressing the organellar genome thymine base editor according to any one of claims 1-6.

8. The expression vector according to claim 7, characterized in that: The expression vector includes a vector for expressing a left fusion protein and a vector for expressing a right fusion protein.

9. The expression vector according to claim 7 or 8, characterized in that: When the organellar genome thymine base editor is used for base editing of plant organelles, the expression vector is driven by a rice Ubi promoter and / or a corn Ubi promoter; when the organellar genome thymine base editor is used for base editing of animal organelles, the expression vector is driven by a human cytomegalovirus promoter; Preferably, the expression vector has a replicon that propagates in Escherichia coli and / or Agrobacterium; Preferably, the expression vector has a selection marker; Preferably, the selection marker is a kanamycin resistance gene or an ampicillin resistance gene.

10. Use of the organellar genome thymine base editor according to any one of claims 1 to 6 or the expression vector according to any one of claims 7 to 9 in the preparation of breeding reagents or gene therapy reagents.

Citation Information

Cited By

  • Base editor and application thereof

    CN121065143A

  • A base editor and applications thereof

    CN121065143B